US$ 26.78
vision loss with tirzepatide loss: GLP-1 drugs like Ozempic linked to 3 eye conditions Zepbound and Vision Loss: An
Description
By mimicking the actions of both glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP), tirzepatide enhances insulin secretion, reduces blood sugar levels, promotes satiety, and aids in weight loss

Patients seeking the highest level of weight loss may be better candidates for tirzepatide

Dual agonism improves glycemic control, delays gastric emptying, reduces caloric intake, and enhances metabolic efficiency

Mishra R, Raj R, Elshimy G, et al

The least squares mean was estimated using an MMRM in all randomized participants who had available data (placebo, n = 33

Discuss any concerns or side effects that you may experience while on this medication with your clinician, who can offer options that reduce any discomfort you may experience